This NVIDIA-Backed AI Startup Could Change the Way We Discover New Drugs

With a $150 million boost in funding, the company aims to integrate advanced AI models with extensive datasets into the drug development process.
Image by Nikhil Kumar
SandboxAQ, a startup focused on AI that emerged from Alphabet’s Google and is supported by NVIDIA, released a large set of data recently aimed at accelerating the identification of new medical therapies by assisting researchers in understanding how drugs attach to proteins. The objective is to enable scientists to predict whether a drug will bind effectively to its target within the human body, Reuters reported. SandboxAQ is a B2B company that provides AI solutions to tackle significant global challenges. Its large quantitative models (LQMs) advance sectors like life sciences, finance, navigation, and cybersecurity. Founded in 2022 as an independent entity from Alphabet, SandboxAQ is backed by notable investors, including T Rowe Price, Eric Schmidt, and Marc Benioff.  SandboxA
Subscribe or log in to Continue Reading

Uncompromising innovation. Timeless influence. Your support powers the future of independent tech journalism.

Already have an account? Sign In.

📣 Want to advertise in AIM? Book here

Picture of Smruthi Nadig
Smruthi Nadig
Smruthi brings over two years of experience in reporting on the global energy industry. They hold a Master's Degree from the University of Leeds in International Journalism and a Bachelor's Degree from Christ University in Media Studies, Economics and Political Science.
Related Posts
AIM Print and TV
Don’t Miss the Next Big Shift in AI.
Get one year subscription for ₹5999
Download the easiest way to
stay informed